Clinical trial
Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia
NCT00477490 · Ferring Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00477490 |
|---|---|
| Title | Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia |
| Official title | A Randomized, Double Blind, Placebo Controlled, Parallel Group, Multi-Center Study With a Double Blind Extension Investigating the Efficacy and Safety of a Fast- Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults |
| Lead sponsor | Ferring Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Nocturia |
| Intervention type | Drug |
| Interventions | desmopressin acetate, Placebo |
| Enrollment | 799 |
| Start date | May 1, 2007 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | May 23, 2007 |
| Last update posted | Nov 2, 2015 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: